BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 25772989)

  • 1. Antiviral and synergistic effects of photo-energy with acyclovir on herpes simplex virus type 1 infection.
    Oh PS; Han YH; Lim S; Vetha BSS; Jeong HJ
    Virology; 2024 Jul; 595():110063. PubMed ID: 38564935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of Some Uracil Nucleosides as Promising Anti-Herpes Simplex Virus 1 Agents.
    Awad SM; Ali SM; Mansour YE; Fatahala SS
    Molecules; 2021 May; 26(10):. PubMed ID: 34069874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host targeted antiviral (HTA): functional inhibitor compounds of scaffold protein RACK1 inhibit herpes simplex virus proliferation.
    Ullah H; Hou W; Dakshanamurthy S; Tang Q
    Oncotarget; 2019 May; 10(35):3209-3226. PubMed ID: 31143369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lexitropsins in antiviral drug development.
    Lown JW
    Antiviral Res; 1992 Mar; 17(3):179-96. PubMed ID: 1314535
    [No Abstract]   [Full Text] [Related]  

  • 5. Acyclovir: mechanism of antiviral action and potentiation by ribonucleotide reductase inhibitors.
    Reardon JE; Spector T
    Adv Pharmacol; 1991; 22():1-27. PubMed ID: 1958500
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of dimeric netropsin analogue 15Lys-bis-Nt and acyclovir on the reproduction of herpes simplex virus type 1. The search for variants of herpes virus with drug resistance to 15Lys-bis-Nt and acyclovir.
    Andronova VL; Grokhovsky SL; Surovaya AN; Gursky GV; Galegov GA
    Dokl Biochem Biophys; 2015; 460():42-6. PubMed ID: 25772989
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antiviral properties of the derivatives of netropsin and distamycin against herpes simplex viruses type 1 and variolovaccine].
    Andronova VL; Grokhovskiĭ SL; Galegov GA; Deriabin PG; Gurskiĭ GV; L'vov DK
    Vopr Virusol; 2010; 55(6):24-7. PubMed ID: 21381336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research of suppression of the herpes simplex virus reproduction with drug resistance using a combination 15-Lys-bis-Nt with some antiherpetic drugs].
    Andronova VL; Grokhovskiĭ SL; Surovaia AN; Deriabin PG; Gurskiĭ GV; Galegov GA
    Vopr Virusol; 2014; 59(1):38-41. PubMed ID: 25065145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estimation of activity of bis-netropsin derivatives based on a model of an experimental cutaneous herpes simplex virus disease of guinea pigs].
    andronova VL; Grokhovskiĭ SL; Surovaia AN; Gurskiĭ GV; Deriabin PG; L'vov DK; Galegov GA
    Vopr Virusol; 2013; 58(1):32-5. PubMed ID: 23785759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiherpetic activity of netropsin derivatives as tested in experiments in laboratory animals].
    Andronova VL; Grokhovskiĭ SL; Deriabin PG; Gurskiĭ GV; Galegov GA; L'vov DK
    Vopr Virusol; 2012; 57(4):24-6. PubMed ID: 23012980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis and antiherpes activity of acyclovir phosphoesters].
    Galegov GA; Shobukhov VM; Leont'eva NA; Ias'ko MV
    Bioorg Khim; 1997 Nov; 23(11):906-9. PubMed ID: 9518431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex of the herpes simplex virus type 1 origin binding protein UL9 with DNA as a platform for the design of a new type of antiviral drugs.
    Bazhulina NP; Surovaya AN; Gursky YG; Andronova VL; Moiseeva ED; Nikitin CA; Golovkin MV; Galegov GА; Grokhovsky SL; Gursky GV
    J Biomol Struct Dyn; 2014; 32(9):1456-73. PubMed ID: 23879454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus.
    Hoopes JD; Driebe EM; Kelley E; Engelthaler DM; Keim PS; Perelson AS; Rong L; Went GT; Nguyen JT
    PLoS One; 2011; 6(12):e29778. PubMed ID: 22220216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro selection and characterization of HCV replicons resistant to multiple non-nucleoside polymerase inhibitors.
    Delang L; Vliegen I; Leyssen P; Neyts J
    J Hepatol; 2012 Jan; 56(1):41-8. PubMed ID: 21703175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complex of the herpes simplex virus initiator protein UL9 with DNA as a platform for the design of a new type of antiviral drugs].
    Surovaia AN; Gorohovskiĭ SL; Gurskiĭ IaG; Andronova VL; Arkhipova VS; Bazhulina NP; Galegov GA; Gurskiĭ GV
    Biofizika; 2010; 55(2):239-51. PubMed ID: 20429277
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.